Transfusion-Related Cost and Time Burden Offsets in Patients with Myelofibrosis Treated with Momelotinib in the SIMPLIFY-1 and SIMPLIFY-2 Trials.
Saved in:
| Title: | Transfusion-Related Cost and Time Burden Offsets in Patients with Myelofibrosis Treated with Momelotinib in the SIMPLIFY-1 and SIMPLIFY-2 Trials. |
|---|---|
| Authors: | Masarova, Lucia1 (AUTHOR) lmasarova@mdanderson.org, Liu, Tom2 (AUTHOR) tom.x.liu@gsk.com, Fillbrunn, Mirko3 (AUTHOR) mirko.fillbrunn@analysisgroup.com, Li, Weilong4 (AUTHOR) weilong.li@analysisgroup.com, Sajeev, Gautam3 (AUTHOR) gautam.sajeev@analysisgroup.com, Rao, Sumati2 (AUTHOR) sumati.a.rao@gsk.com, Gorsh, Boris2 (AUTHOR) bgorsh@gmail.com, Signorovitch, James3 (AUTHOR) james.signorovitch@analysisgroup.com |
| Source: | Cancers. Dec2024, Vol. 16 Issue 23, p4067. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
